SNCG and early-onset autosomal dominant Alzheimer disease: However, synuclein aggregation is observed in other diseases, and aging, as evidenced by an analysis of confirmed Alzheimer’s disease cases at the Mayo clinic, which showed that 54% also had synuclein pathology [42].